Find out how Profil can help you simplify your operations, regardless of how your study is designed.
As Profil has specialized on early phase studies, where often very few units are needed, we are able to manufacture IMPs in small scales (e.g. up to 100 units). Profil can adapt to your tight deadline and delivers top quality in labelling and packaging.
Our experts of IMP listen to your needs at every step of the process. We deliver in accordance to your needs and clinical trial requirements. Our strength is our flexibility in production volume. We can produce very short shelf life IMPs (<72 h) on demand and ship them within the EU.
Our facilities at Profil are specially designed to create an ideal environment for pharmaceutical packaging and manufacturing. We have several cleanrooms for manufacturing, packaging and labelling of IMPs with a total area of 123 qm. Our GMP facilities are under regular supervision of health authorities. We have passed several audits by our clients as well as EMA, FDA and our local competent authorities.
Contact us today and have a talk with our experts about your clinical trial projects.
ISO 13485:2016
|
ISO 9001:2015
|
Kapitza, C. et al. 2021. A single-dose euglycaemic clamp study in two cohorts to compare the exposure of SAR341402 (insulin aspart) Mix 70/30 with US- and European-approved versions of insulin aspart Mix 70/30 and SAR341402 rapid-acting solution in subjects with type 1 diabetes. Diabetes Obes Metab. 2021 Mar;23(3):674-681.